A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin

Overview of attention for article published in Frontiers in oncology, October 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet

twitter: 8 X users

Citations

dimensions_citation: 70 Dimensions

Readers on

mendeley: 84 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma

Cancer Cell International, 05 Oct 2023

Abstract Objectives RAD51 overexpression has been reported to serve as a marker of poor prognosis in several cancer types.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.